CAR-T（CAR-T）细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T（CAR-T）细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
勘误：CD4(+)CD25(+)CD127(low) 调节性 T 细胞与 CD19 CAR-T 治疗复发/难治性 B 细胞急性淋巴细胞白血病疗效的关联 [Int. Immunopharmacol. 96 (2021) 107742]
英文原题：Corrigendum to "CD4(+)CD25(+)CD127(low) regulatory T cells associated with the effect of CD19 CAR-T therapy for relapsed/refractory B-cell acute lymphoblastic leukemia" [Int. Immunopharmacol. 96 (2021) 107742].
查看英文原题
Corrigendum to "CD4(+)CD25(+)CD127(low) regulatory T cells associated with the effect of CD19 CAR-T therapy for relapsed/refractory B-cell acute lymphoblastic leukemia" [Int. Immunopharmacol. 96 (2021) 107742].
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
摘要
这条来源本身就没有摘要（PubMed 未提供），不是「还没翻译」。可以点最下面的「在 PubMed 查看」打开原文献页面。
论文信息
- 作者
- Pan Y、Wang H、An F、Wu F、Tao Q、Li Y、Ruan Y、Zhai Z
- 第一作者单位
- Hematology Department, the Second Hospital of Anhui Medical University (SHAMU), Hefei, Anhui Province, China; Hematologic Diseases Research Center of Anhui Medical University, Hefei, Anhui Province, China.China
- 通讯作者单位
- Hematology Department, the Second Hospital of Anhui Medical University (SHAMU), Hefei, Anhui Province, China; Hematologic Diseases Research Center of Anhui Medical University, Hefei, Anhui Province, China. Electronic address: zzzm889@163.com.China
- 文献类型
- 勘误
- 期刊
- International immunopharmacology2022 Jan
- 原文标识
- PubMed 34656428 · DOI 10.1016/j.intimp.2021.108194